Abcam is a global life science company supporting scientists at the forefront of life science research, accelerating breakthroughs that can positively impact people’s lives.
Abcam’s mission is to provide the life sciences community with the proteomic tools and solutions they need to accelerate their next breakthrough and help translate them into new discoveries, in vitro diagnostics or therapies that have the potential to improve human health.
Serving the healthcare and life science sector globally
With over 20 years of experience, Abcam is a leading global proteomics pioneer that identifies, develops, and manufactures quality biological, protein, and custom cell engineering tools. These reagents are available to the life science community together with comprehensive data, fast delivery, helpful customer service and technical support.
From its headquarters on the Cambridge Biomedical Campus and its facilities across Europe, USA and Asia, the Company serves around 750 000 life scientists in academia and research institutes, as well as pharmaceutical, biotechnology and diagnostics companies in over 130 countries.
Supporting tomorrow’s needs through innovation
Driven to support the industry’s evolving needs, Abcam is committed to continuously innovate to provide solutions that can support faster discoveries, leveraging all areas of the business including growing in-house new product development, scaling up manufacturing, promoting science reproducibility, and enabling digital transformation. When combined with its commercialisation prowess, technical expertise and round-the-clock delivery, scientists are ensured rapid access to the newest and best proteomic research tools available globally.
Progress through partnership
Collaborations are playing an ever-increasing role in the life sciences to achieve successful outcomes at speed. To date*, Abcam has delivered custom-engineered solutions and support for over 2000 collaborative projects, of which 450 are used on third-party platforms or for diagnostic use.
Leveraging its proprietary platforms and world-leading expertise, together with a flexible commercial approach, Abcam is building long-term synergistic partnerships across the life science sector to co-create precision tools and novel reagents that would ultimately help improving diagnoses, treatments and human health and wellbeing.
* as of Q4 2020
corporate.abcam.com
